ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0684

The Diagnostic Accuracy of Ultrasound for Low Muscle Mass in Women with Systemic Sclerosis

Lucas Dória1, Vanessa Hax2, André Mallmann2, Rafaela Santo3, Leonardo Santos2, Stephanie Pilotti2, Daniel Moraes2, Isabella Boening2, Pedro Glanze2, ODIRLEI MONTICIELO1, Ricardo Xavier4 and Rafael Chakr5, 1Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil, 2Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil, 3Health Research and Innovation Science Centre, Klaipeda University, Klaipeda, Lithuania, Porto Alegre, Rio Grande do Sul, Brazil, 4Universidade Federal do Rio Grande do Sul, Porto Alegre/RS, Rio Grande do Sul, Brazil, 5Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

Meeting: ACR Convergence 2024

Keywords: Dual energy x-ray absorptiometry (DEXA), Muscle Function, Musculoskeletal Examination, Scleroderma, Systemic, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Systemic Sclerosis & Related Disorders – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Patients with systemic sclerosis (SSc) often experience body composition changes, including low muscle mass (myopenia), associated with physical disability, hospitalization and death. Our purpose was to estimate the best cut-off value for low muscle mass diagnosis in SSc patients using ultrasound (US) for muscle thickness measurement.

Methods: This study has been approved in accordance with the Declaration of Helsinki principles and all subjects provided written informed consent. Women meeting the ACR/EULAR 2013 SSc criteria were consecutively enrolled between 2022 and 2023. Electronic medical records provided data on age, disease duration, cutaneous subtype, modified Rodnan’s skin score (mRSS), and the EUSTAR activity index. 

Appendicular skeletal muscle mass (ASM, kg) was quantified by dual-energy X-ray absorptiometry (DXA). Low muscle mass was defined as ASM < 15 kg. Muscle thickness of vastus lateralis (VL, cm) was assessed real-time. Two independent investigators measured the VL images, and the mean of their measurements was considered for analysis . Pearson correlation coefficient, diagnostic accuracy (sensitivity, specificity, ROC curve, and AUC), and Kappa concordance were analyzed (p< 0.05). 

Results: Eighty patients were included [mean age of 60.7±11.2 years old and a median disease duration of 11.0 (5.0–18.5) years]. Twenty percent of the participants had diffuse cutaneous SSc. The median mRSS was 4.0 (2.0–7.8), and the median EUSTAR index was 1.7 (1.1–3.1). The mean ASM was 16.0 ± 2.3 kg and 25% of patients showed low ASM. The mean thickness of VL was 1.8±0.4 cm. Low ASM was associated with low muscle thickness of VL (r=0.601, p< 0.001). The AUC for VL versus ASM was 0.849 (95% CI: 0.764-0.935, p< 0.001, Figure 1). The estimated VL cut-off was 1.26 cm, with 90.0% sensitivity and 75.0% specificity compared to ASM (Kappa=0.534, p< 0.001).

Conclusion: In our study, VL thickness measured by US was associated with low ASM by DXA and a cut-off of 1.26 cm was sensitive enough to encourage future research on the use of US as a screening and monitoring tool for myopenia in SSc women. 

Supporting image 1

Figure 1. ROC curve of vastus lateralis thickness in comparison to low appendicular skeletal muscle mass by DXA


Disclosures: L. Dória: None; V. Hax: None; A. Mallmann: None; R. Santo: None; L. Santos: None; S. Pilotti: None; D. Moraes: None; I. Boening: None; P. Glanze: None; O. MONTICIELO: AbbVie/Abbott, 6, AstraZeneca, 6, GlaxoSmithKlein(GSK), 6, Janssen, 6, UCB, 6; R. Xavier: None; R. Chakr: None.

To cite this abstract in AMA style:

Dória L, Hax V, Mallmann A, Santo R, Santos L, Pilotti S, Moraes D, Boening I, Glanze P, MONTICIELO O, Xavier R, Chakr R. The Diagnostic Accuracy of Ultrasound for Low Muscle Mass in Women with Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/the-diagnostic-accuracy-of-ultrasound-for-low-muscle-mass-in-women-with-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-diagnostic-accuracy-of-ultrasound-for-low-muscle-mass-in-women-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology